Non-Genomic Control of Dynamic MYCN Gene Expression in Liver Cancer
Upregulated gene expression is restricted to specialized cell populations such as EpCAM cancer stem cells in liver cancer, regardless of DNA amplification and mutation. Here, we reviewed the role of gene expression in liver homeostasis, regeneration, and tumorigenesis, and discussed the potential no...
Saved in:
Published in: | Frontiers in oncology Vol. 10; p. 618515 |
---|---|
Main Authors: | , |
Format: | Journal Article |
Language: | English |
Published: |
Switzerland
Frontiers Media S.A
16-04-2021
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Upregulated
gene expression is restricted to specialized cell populations such as EpCAM
cancer stem cells in liver cancer, regardless of DNA amplification and mutation. Here, we reviewed the role of
gene expression in liver homeostasis, regeneration, and tumorigenesis, and discussed the potential non-genomic mechanisms involved in controlling
gene expression in liver cancer, with a focus on inflammation-mediated signal transduction and microRNA-associated post-transcriptional regulation. We concluded that dynamic
gene expression is an integrated consequence of multiple signals in the tumor microenvironment, including tumor growth-promoting signals, lipid desaturation-mediated endoplasmic reticulum stress adaptation signals, and tumor suppressive miRNAs, making it a potential predictive biomarker of tumor stemness and plasticity. Therefore, understanding and tracing the dynamic changes and functions of
gene expression will shed light on the origin of liver tumorigenesis at the cellular level and the development of novel therapeutic and diagnostic strategies for liver cancer treatment. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 Edited by: Yusuke Suenaga, Chiba Cancer Center, Japan Reviewed by: Shoma Tsubota, Nagoya University, Japan; Alexander Schramm, Essen University Hospital, Germany This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology |
ISSN: | 2234-943X 2234-943X |
DOI: | 10.3389/fonc.2020.618515 |